Search

everythinglearnresearchcommunity

for

Search:↓

The combined therapy was effective and safe for children with severe alopecia areata.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Some children and young adults with eyebrow and eyelash hair loss actually have a hair-pulling disorder, often with related psychological issues.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Exclamation mark hairs are not exclusive to alopecia areata.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

A new mouse model helps understand and find treatments for alopecia areata.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Korean Red Ginseng may help improve hair regrowth when used with corticosteroid injections for Alopecia Areata.

Botulinum toxin type A injections are not effective for severe alopecia areata.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Some treatments like pentoxifylline with topical corticosteroids might work for alopecia areata, but more research is needed to find the best one.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.